Brought to you by
In our network
logo logo logo

Contact Information

Queen Elizabeth University Hospital 1345 Govan Road,

G51 4TF - Glasgow

United Kingdom

 +44 (0) 141 451 1328

Harper VanSteenhouse

President, BioClavis, United Kingdom

BioClavis is a Glasgow-based personalised diagnostics spin-out of BioSpyder Technologies. We leverage the proprietary TempO-Seq® transcriptomic/genomic platform technology, capable of efficiently analysing large cohorts with customisable biomarker panels of tens to thousands of genes, quickly and inexpensively. Therefore, we’re enabling the full promise and clinical utility of ‘omic testing to deliver cost-effective care for individual patients in coordination with and context of the practical realities in today’s healthcare systems.

TempO-Seq has critical usability features, controls, and does not require specialised instrumentation, ideal for expansion into the clinic. These strengths – in concert with centralised patient samples, clinical research partners, and economic decision making – allow accelerating content discovery, product development and adoption of a new generation of cost-disruptive precision medicine testing worldwide.

Live Online Event: UK Timezone,

Feb 08

Investing in Health Tech and Precision Medicine

By continuing to use the site, you agree to the use of cookies. Read our cookie policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.